Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.7465
-0.0275 (-3.55%)
At close: May 6, 2026, 4:00 PM EDT
0.7465
0.00 (0.00%)
Pre-market: May 7, 2026, 6:52 AM EDT
Mustang Bio Employees
Mustang Bio had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$680,750
Market Cap
5.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -74 | -92.50% |
| Dec 31, 2023 | 80 | -33 | -29.20% |
| Dec 31, 2022 | 113 | 11 | 10.78% |
| Dec 31, 2021 | 102 | 40 | 64.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| BiomX | 20 |
| Cardio Diagnostics Holdings | 17 |
| BioRestorative Therapies | 14 |
| Purple Biotech | 10 |
| Dermata Therapeutics | 9 |
| CNS Pharmaceuticals | 5 |
MBIO News
- 10 months ago - Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga
- 10 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - GlobeNewsWire
- 1 year ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 1 year ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 1 year ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire